Development of RNA-SSCP protocols for the identification and screening of CFTR mutations: Identification of two new mutations
β Scribed by L. Bisceglia; A. Grifa; L. Zelante; P. Gasparini
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 384 KB
- Volume
- 4
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
β¦ Synopsis
A strategy is described that allows a rapid and accurate identification and screening of cystic fibrosis gene mutations. It consists of setting up and developing RNA single strand conformation polymorphism (rSSCP) protocols, a technique based on the large repertoire of secondary structure of singlestranded RNA. By incorporating the T7 phage promoter sequence into PCR primers, it is possible to carry out rSSCP and compare it to standard singleestrand conformation polymorphism (SSCP). Several parallel tests indicate that rSSCP detects a higher fraction of single base changes, and is less time consuming than SSCP since it requires only one fairly short electrophoretic run. Using this technique we were able to identify two new splicing mutations in introns 5 (711 +5G+A) and 10 ( 1 7 1 7 -8 G A ) of the CFTR gene. o 1994 WiIeyLiss, Inc.
π SIMILAR VOLUMES
Communicated by Garry R. Cutting In the search for mutations in the cystic fibrosis gene in patients from the Mediterranean area, we have analysed exons 4,9, 10, 19, and 21 by the single-strand conformation polymorphism (SSCP) technique in 50 patients with at least one non-AF508 chromosome. Ten sam
In this study we have analyzed the factor IX gene from 84 hemophilia B patients of Spanish origin. It included single-strand conformation polymorphism (SSCP) analysis of all functional regions of the gene and further sequencing of all fragments showing abnormal migration. In 76 patients (90.4%), it
Cystic fibrosis (CF) is one of the most common severe autosomal recessive disease in Caucasians,
We have analyzed 39 unrelated cystic fibrosis (CF) families by denaturing gradient gel electrophoresis (DGGE) and direct sequencing in order to determine the spectrum of CF mutations in our population. This approach has allowed us to detect 72 out of the 78 CF chromosomes (92.3%). The DF508 mutation